Lars Bangsgaard
Chairman chez QLIFE HOLDING AB
Profil
Lars Bangsgaard founded Qlife ApS in 2018, Atonomics A in 2000, where he worked as Chief Financial Officer from 2001 to 2014, and Qlife Holding AB in 2019, where he worked as Chief Financial Officer from 2019 to 2020.
Mr. Bangsgaard also currently works at Altia Invest ApS, as Chief Executive Officer from 2011, Qlife Holding AB, as Chairman from 2023, and Petel Holding A, as Director from 2000.
Mr. Bangsgaard received his graduate degree from Copenhagen Business School.
Postes actifs de Lars Bangsgaard
Sociétés | Poste | Début |
---|---|---|
QLIFE HOLDING AB | Chairman | 01/01/2023 |
Petel Holding A/S | Director/Board Member | 19/09/2000 |
Altia Invest ApS | Chief Executive Officer | 15/08/2011 |
Anciens postes connus de Lars Bangsgaard
Sociétés | Poste | Fin |
---|---|---|
Qlife ApS | Founder | - |
QLIFE HOLDING AB | Founder | - |
Atonomics A/S
Atonomics A/S Electronic Equipment/InstrumentsElectronic Technology Atonomics A/S provides diagnostic equipment for the biotechnology industries. Its product Atolyzer, is a microscopic biosensor that applies surface acoustic waves in the measurement of low levels of biomarkers in biological samples. The firm develops products for the benefit of health care professionals and patients. The company was founded by Thomas Warthoe, Peter Warthoe and Lars Bangsgaard on October 5, 2000 and is headquartered in Copenhagen, Denmark. | Founder | - |
Formation de Lars Bangsgaard
Copenhagen Business School | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
QLIFE HOLDING AB | Health Technology |
Entreprise privées | 4 |
---|---|
Atonomics A/S
Atonomics A/S Electronic Equipment/InstrumentsElectronic Technology Atonomics A/S provides diagnostic equipment for the biotechnology industries. Its product Atolyzer, is a microscopic biosensor that applies surface acoustic waves in the measurement of low levels of biomarkers in biological samples. The firm develops products for the benefit of health care professionals and patients. The company was founded by Thomas Warthoe, Peter Warthoe and Lars Bangsgaard on October 5, 2000 and is headquartered in Copenhagen, Denmark. | Electronic Technology |
Altia Invest ApS | |
Qlife ApS | |
Petel Holding A/S |